24 May 2013
Keywords: tekmira, expects, 2m, alnylam, canada-based, pharmaceuticals, says
Article | 19 January 2009
Canada-based Tekmira Pharmaceuticals says that it expects to receive a minimum of $11.2 million over the next three years from its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.